ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY
Clinical trials for ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY explained in plain language.
Never miss a new study
Get alerted when new ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY trials appear
Sign up with your email to follow new studies for ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill aims to calm dangerous heartbeats in genetic disorder
Disease control Recruiting nowThis study is testing whether an oral drug called tideglusib can help control a genetic heart condition that causes dangerous irregular heartbeats. It will involve 120 people who have a specific gene change linked to the disease and experience frequent extra heartbeats. Participa…
Matched conditions: ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY
Phase: PHASE2 • Sponsor: Hamilton Health Sciences Corporation • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Scientists test if ARVC patients can safely exercise more
Knowledge-focused Recruiting nowThis study aims to measure how much strain different exercises put on the hearts of people with ARVC, a genetic heart condition. Researchers will monitor 120 patients with ARVC while they perform activities like walking, cycling, and light weightlifting. The goal is to gather dat…
Matched conditions: ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY
Phase: NA • Sponsor: Swiss Federal Institute of Technology • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:38 UTC